BR112012019136A2 - polímeros solúveis de glicose ramificados para a diálise peritonel. - Google Patents

polímeros solúveis de glicose ramificados para a diálise peritonel.

Info

Publication number
BR112012019136A2
BR112012019136A2 BR112012019136-5A BR112012019136A BR112012019136A2 BR 112012019136 A2 BR112012019136 A2 BR 112012019136A2 BR 112012019136 A BR112012019136 A BR 112012019136A BR 112012019136 A2 BR112012019136 A2 BR 112012019136A2
Authority
BR
Brazil
Prior art keywords
soluble polymers
branched glucose
peritoneal dialysis
glucose soluble
range
Prior art date
Application number
BR112012019136-5A
Other languages
English (en)
Other versions
BR112012019136B1 (pt
Inventor
Guerin-Deremaux Laettia
Petit Jean Carole
Wils Daniel
Original Assignee
Roquette Freres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres filed Critical Roquette Freres
Publication of BR112012019136A2 publication Critical patent/BR112012019136A2/pt
Publication of BR112012019136B1 publication Critical patent/BR112012019136B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B30/00Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
    • C08B30/12Degraded, destructured or non-chemically modified starch, e.g. mechanically, enzymatically or by irradiation; Bleaching of starch
    • C08B30/18Dextrin, e.g. yellow canari, white dextrin, amylodextrin or maltodextrin; Methods of depolymerisation, e.g. by irradiation or mechanically
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/718Starch or degraded starch, e.g. amylose, amylopectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287Dialysates therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B30/00Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
    • C08B30/12Degraded, destructured or non-chemically modified starch, e.g. mechanically, enzymatically or by irradiation; Bleaching of starch
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B30/00Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
    • C08B30/20Amylose or amylopectin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L3/00Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
    • C08L3/02Starch; Degradation products thereof, e.g. dextrin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/18Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

polímeros solúveis de glicose ramificados para a diálise peritoneal. a presente invenção refere-se a polímeros solúveis de glicose ramificados preparados a partir de amido que apresentam um teor de amilose de pelo menos 30% em peso, preferencialmente compreendido entre 35% e 80% em peso, que apresentam um teor de ligações glicosídicas <244>-1,6 compreendido entre 7% e 10%, preferencialmente compreendido entre 8% e 9% e um mw compreendido entre 50.000 e 150.000 dalton, caracterizados pelo fato de apresentarem uma resistência à alfa amilase pancreática, expressa de acordo com um teste b por um teor de açúcares redutores compreendido entre 25% e 35% e um mw de produtos libertados compreendido entre 6.000 e 12.000 dalton.
BR112012019136-5A 2010-02-02 2011-02-01 polímeros solúveis de glicose ramificados, processo para preparação dos mesmos, composições e solução para diálise peritoneal compreendendo os referidos polímeros BR112012019136B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1050736 2010-02-02
FR1050736A FR2955861B1 (fr) 2010-02-02 2010-02-02 Polymeres solubles de glucose branches pour la dialyse peritoneale
PCT/FR2011/050201 WO2011095736A1 (fr) 2010-02-02 2011-02-01 Polymeres solubles de glucose branches pour la dialyse peritoneale

Publications (2)

Publication Number Publication Date
BR112012019136A2 true BR112012019136A2 (pt) 2018-03-27
BR112012019136B1 BR112012019136B1 (pt) 2021-01-19

Family

ID=42340838

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012019136-5A BR112012019136B1 (pt) 2010-02-02 2011-02-01 polímeros solúveis de glicose ramificados, processo para preparação dos mesmos, composições e solução para diálise peritoneal compreendendo os referidos polímeros

Country Status (11)

Country Link
US (1) US9200087B2 (pt)
EP (1) EP2531531B1 (pt)
JP (1) JP5822402B2 (pt)
CN (1) CN102741296B (pt)
BR (1) BR112012019136B1 (pt)
CA (1) CA2786428C (pt)
ES (1) ES2931925T3 (pt)
FR (1) FR2955861B1 (pt)
MX (1) MX340829B (pt)
PL (1) PL2531531T3 (pt)
WO (1) WO2011095736A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2983514A4 (en) 2013-03-15 2017-03-15 Cargill, Incorporated Carbohydrate compositions
CN105524181B (zh) * 2014-10-23 2017-12-08 华仁药业股份有限公司 艾考糊精原料药全新合成工艺
CN104544473A (zh) * 2014-12-08 2015-04-29 江南大学 一种抑制淀粉回生的生物改性方法
DE102015014699A1 (de) * 2015-11-13 2017-05-18 Fresenius Medical Care Deutschland Gmbh Dialyselösung mit wenigstens einem Osmotikum
WO2017211376A1 (de) * 2016-06-11 2017-12-14 Gea Tds Gmbh Verfahren und anlage zur reinigung von flüssigzucker, hergestellt aus kristallzucker minderer reinheit
FR3055898B1 (fr) * 2016-09-15 2018-11-02 Roquette Freres Nouveaux polymeres de glucose pour dialyse peritoneale
EP3381484A1 (en) * 2017-03-31 2018-10-03 Opterion Health AG Carbohydrate composition for dialysis
CN108020576A (zh) * 2017-10-12 2018-05-11 青岛力腾化工医药研究有限公司 一种利用核磁共振对葡萄糖聚合物支化度测定的方法
FR3077959B1 (fr) * 2018-02-22 2021-09-24 Roquette Freres Procede de fabrication de dextrine de pois resistante
CN111215017B (zh) * 2019-12-10 2021-06-25 山东省鲁洲食品集团有限公司 防止液体糊精储存过程中老化的装置及其方法
WO2023159172A1 (en) 2022-02-17 2023-08-24 Cargill, Incorporated Resistant dextrins and methods of making resistant dextrins
WO2023159173A1 (en) 2022-02-17 2023-08-24 Cargill, Incorporated Resistant dextrins and methods of making resistant dextrins
WO2023159175A1 (en) 2022-02-17 2023-08-24 Cargill, Incorporated Resistant dextrins and methods of making resistant dextrins
WO2023159171A1 (en) 2022-02-17 2023-08-24 Cargill, Incorporated Resistant dextrins and methods of making resistant dextrins

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1444901A (en) * 1972-05-02 1976-08-04 Milner Scient Medical Research Glucose polymers
ATE106410T1 (de) 1985-06-22 1994-06-15 Ml Lab Plc In kontinuierlicher peritonealdialyse verwendete polymere.
FR2716199B1 (fr) 1994-02-15 1996-04-26 Roquette Freres Procédé de fabrication d'un hydrolysat d'amidon à faible indice de polymolécularité, nouvel hydrolysat d'amidon ainsi obtenu et son utilisation en dialyse péritonéale.
US5922379A (en) * 1998-05-05 1999-07-13 Natural Polymer International Corporation Biodegradable protein/starch-based thermoplastic composition
FR2792941B1 (fr) 1999-04-30 2001-07-27 Roquette Freres Polymeres solubles de glucose branches et leur procede d'obtention
US20020065410A1 (en) * 1999-12-02 2002-05-30 Antrim Richard L. Branched starches and branched starch hydrolyzates
US20020018837A1 (en) * 2000-05-27 2002-02-14 Lanner David Arthur Dough for making tortilla chips with controlled surface bubbling
US7709230B2 (en) * 2001-04-27 2010-05-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for producing isomaltose and uses thereof
FR2840612B1 (fr) 2002-06-06 2005-05-06 Roquette Freres Polymeres solubles de glucose hautement branches et leur procede d'obtention
WO2003106502A1 (en) * 2002-06-17 2003-12-24 Novozymes A/S Methods for producing dextrins using enzymes
DE10237442B4 (de) * 2002-08-16 2004-08-19 Fresenius Kabi Deutschland Gmbh Hochverzweigte, niedrig substituierte Stärkeprodukte
FR2864088B1 (fr) * 2003-12-19 2006-04-28 Roquette Freres Polymeres solubles de glucose hautement branches
US7118857B2 (en) 2004-02-27 2006-10-10 Baxter International Inc. Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions
JP5307387B2 (ja) * 2004-09-30 2013-10-02 江崎グリコ株式会社 高分岐かつ高分子量のグリコーゲン
FR2897869B1 (fr) 2006-02-28 2011-05-06 Roquette Freres Polymeres solubles de glucose hautement branches pour la nutrition enterale, parenterale et pour la dialyse peritoneale
EP1943908A1 (en) * 2006-12-29 2008-07-16 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Novel slowly digestible storage carbohydrate
KR100868329B1 (ko) * 2007-02-01 2008-11-12 씨제이제일제당 (주) 효소를 이용한 고분지 아밀로오스 및 아밀로펙틴클러스터의 제조방법
CN100509854C (zh) * 2007-04-19 2009-07-08 成都新柯力化工科技有限公司 一种直链淀粉的制备方法

Also Published As

Publication number Publication date
BR112012019136B1 (pt) 2021-01-19
JP2013518562A (ja) 2013-05-23
CN102741296B (zh) 2016-03-02
JP5822402B2 (ja) 2015-11-24
PL2531531T3 (pl) 2022-12-19
EP2531531B1 (fr) 2022-09-14
FR2955861B1 (fr) 2013-03-22
ES2931925T3 (es) 2023-01-04
CA2786428A1 (fr) 2011-08-11
US9200087B2 (en) 2015-12-01
MX340829B (es) 2016-07-26
EP2531531A1 (fr) 2012-12-12
US20120295873A1 (en) 2012-11-22
MX2012008919A (es) 2012-08-15
CA2786428C (fr) 2017-07-18
CN102741296A (zh) 2012-10-17
WO2011095736A1 (fr) 2011-08-11
FR2955861A1 (fr) 2011-08-05

Similar Documents

Publication Publication Date Title
BR112012019136A2 (pt) polímeros solúveis de glicose ramificados para a diálise peritonel.
BR112012011294A2 (pt) composição nutritiva para promover o equilíbrio de microbiotas do intestino e a saúde
BR112014013695A2 (pt) composição estabilizante de atrito simultâneo tendo uma resistência gel superior
BR112016013148A2 (pt) &#34;composições de rnai de componente do complemento e métodos de utilização das mesmas
BRPI1002587A2 (pt) composição e produto de reação
BR112018007982A2 (pt) composição, reação enzimática e método para preparar um copolímero de enxerto
BRPI1003178A2 (pt) composição
BR112013002875A2 (pt) composições de carboidratos
BR112015000320A2 (pt) composições farmacêuticas dissuasivas de abuso, de liberação prolongada
BR112015032249A2 (pt) copolímero heterofásico
BRPI1002586A2 (pt) Composição que compreende pelo menos um polímero polar modificado lipossolúvel com teor elevado de carbono
BR112013016610A2 (pt) bebidas prontas para beber compreendendo grão integral hidrolisado
BR112012029566A2 (pt) composição.
BR112014005134A2 (pt) composição farmacêutica de dissolução rápida
BR112015015408A2 (pt) composição de revestimento, e, artigo revestido
BR112014029286A2 (pt) composição cosmética sólida, processo para sua produção, produto e método cosmético
BR112015030100A2 (pt) processo para a preparação de um polímero de propileno
BR112015023249A2 (pt) composição de carboidrato contendo fibra
BRPI0803424A2 (pt) mistura hidrocoloidal para textura inovadora
BR112012020714A2 (pt) ndbr bimodal.
BR112016006623A2 (pt) biscoito para o café da manhã com glicose de liberação lenta
BR112012013922A2 (pt) composição de grão inteiro hidrolisado
EA032918B1 (ru) Съедобная композиция ресвератрола и моноглюкозида флавоноида для снижения постпрандиальной пиковой амплитуды уровня глюкозы в крови или гликемической реакции
BR112015005134A2 (pt) composições adesivas e uso das mesmas
BR112015013517A2 (pt) composição compreendendo um polímero baseado em etileno e artigo

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/02/2011, OBSERVADAS AS CONDICOES LEGAIS.